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Purpose. We evaluated the inﬂuence of the time between low-dose gadolinium (Gd) contrast administration and coronary vessel
wall enhancement (LGE) detected by 3T magnetic resonance imaging (MRI) in healthy subjects and patients with coronary artery
disease (CAD). Materials and Methods. Four healthy subjects (4 men, mean age 29 ± 3 years and eleven CAD patients (6 women,
mean age 61±10 years) were studied on a commercial 3.0 Tesla (T) whole-body MR imaging system (Achieva 3.0 T; Philips, Best,
The Netherlands). T1-weighted inversion-recovery coronary magnetic resonance imaging (MRI) was repeated up to 75 minutes
afteradministrationoflow-doseGadolinium(Gd)(0.1mmol/kgGd-DTPA).Results. LGEwasseeninnoneofthehealthysubjects,
howeverinalloftheCADpatients.InCADpatients,ﬁfty-sixof62(90.3%)segmentsshowedLGEofthecoronaryarteryvesselwall
at time-interval 1 after contrast. At time-interval 2, 34 of 42 (81.0%) and at time-interval 3, 29 of 39 evaluable segments (74.4%)
were enhanced. Conclusion. In this work, we demonstrate LGE of the coronary artery vessel wall using 3.0 T MRI after a single,
low-dose Gd contrast injection in CAD patients but not in healthy subjects. In the majority of the evaluated coronary segments in
CAD patients, LGE of the coronary vessel wall was already detectable 30–45 minutes after administration of the contrast agent.
1.Introduction
Although invasive X-ray coronary angiography (XCA) is
the current clinical standard for visualizing the coronary
artery lumen, it does not directly image the vessel wall and
oftenunderestimates the extent of underlying atherosclerotic
burden. These disadvantages, as well as the requirement
for intracoronary contrast administration, limit its value
for early disease detection, characterization of plaque com-
ponents [1], and for following the impact of disease-
modifying therapeutic interventions. Magnetic resonance
imaging(MRI)providesexcellentsofttissuecharacterization
and allows the noninvasive evaluation of atherosclerotic
plaques in animal models [2] and patients [3, 4].
Despite the constant motion, small caliber and deep
location of the coronary arteries within the chest, the in vivo
coronary vessel wall in proximal and mid coronary artery
segments can often be well visualized by 1.5T MRI [5, 6].
Simultaneously, late gadolinium-enhanced (LGE) MRI of
the vascular wall is a very promising method for evaluating
carotid and aortic plaque, inﬂammatory vasculopathies, and
for identifying some plaque components, including the
ﬁbrous cap [7–10].
Initial coronary artery vessel wall LGE studies demon-
strated the potential utility of LGE-MRI at 1.5T for coro-
nary plaque visualization and characterization using a T1-
weighted MRI technique with an inherent high contrast
between enhancing and nonenhancing tissue [1, 11–13].
However, in all these early studies, a double or triple
dose of Gadolinium (Gd) was injected, the time course of
enhancementwasnotwellcharacterizeddespiteawiderange
of image acquisition-times (60 to 180 minutes post contrast2 Cardiology Research and Practice
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Figure 1: (a) Formatted coronary magnetic resonance angiography (MRCA) of the right coronary artery (RCA) indicated by white arrows.
(b) No enhancement of the coronary artery vessel wall can be observed on the precontrast (b) and 30 minutes postcontrast administration
(c) acquired inversion-recovery coronary vessel wall scans of the RCA.
administration) [1, 11–13], and investigations were limited
to 1.5T magnetic ﬁeld strength only.
In this study, we examined coronary artery vessel wall
LGE in healthy subjects and patients with established and
stable CAD by using 3.0T MRI after a single, low-dose
contrast injection. We also investigated the eﬀect of time
from contrast administration to the MRI scan on coronary
v e s s e lw a l lL G E .
2.MaterialsandMethods
2.1. Study Population and Design. For imaging of healthy
subjects, the study was conducted in accordance with the
standards of the Charit´ e institutional ethics committee. For
MRI of CAD patients, the study protocol was approved
by the Johns Hopkins Institutional Review Board and
all CAD patients gave written informed consent prior to
participation. Four healthy subjects (4 men, age 29 ± 3) and
elevenpatients(5men,6women,age44–76years,mean61 ±
10 years) were prospectively enrolled. Healthy subjects were
deﬁned as those without a history of CAD and the absence of
traditionalCADriskfactorsotherthanmalegender.AllCAD
subjects had a clinical history of CAD, deﬁned by previous
revascularization including percutaneous coronary interven-
tion, coronary artery bypass grafting, or prior myocar-
dial infarction. Patient demographics are summarized in
Table 1.
2.2. Magnetic Resonance Coronary Artery Lumen and Wall
Imaging. All participants were examined in the supine
position using a commercial 3.0T whole-body MR imag-
ing system (Achieva 3.0T; Philips, Best, The Netherlands)
equipped with a Quasar Dual gradient system (80mT/m,
200T/m/s slew rate). A six-element cardiac phased-array coil
was used for signal reception. Cardiac synchronization was
Table 1: Patient characteristics. BMI = body mass index; CAD =
coronary artery disease; PCI = percutaneous coronary intervention;
CABG = coronary artery bypass graft; LVEF = left ventricular ejec-
tion fraction (derived from echocardiography); GFR = glomerular
ﬁltration rate. Values are expressed as mean ± one standard
deviation.
Patient characteristics
sex, F/M 6/5
age, y 61 ± 10
age range 44–76
BMI, kg/m2 27.1 ± 4.2
Medical history information, n (%)
hypertension 9 (82)
diabetes mellitus 4 (36)
hyperlipoproteinemia 9 (82)
history of smoking 4 (36)
previous PCI 7 (64)
previous CABG 4 (36)
prior myocardial infarction 6 (55)
LVEF (%) 50.5 ± 9.0
GFR (mL
∗min−1∗(1.73m2)−1) 81.3 ± 22.6
Medication
beta-blocker 6 (55)
statins 10 (91)
ACE-inhibitors 5 (45)
performed using a vector electrocardiogram [14]. All sub-
jects underwent a standardized MR examination consisting
of the following steps.
For localization of the heart in the three standard
planes (axial, coronal, and sagittal), a rapid segmented k-
spacegradientechoimagingsequence(multistack,multislice
survey scan, TR/TE/ﬂip angle = 3.8ms/1.8 ms/20◦)wasus ed .Cardiology Research and Practice 3
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Figure 2: (a) No enhancement of the coronary artery vessel wall can be observed on the pre-contrast inversion-recovery coronary vessel
wall scans of the right coronary artery (RCA). (b) Formatted coronary magnetic resonance angiography (MRCA) in the same orientation
demonstrating no high-grade stenosis. (d) Corresponding invasive catheterization of the RCA conﬁrming MRCA ﬁndings. (c) Contrast
uptake of coronary artery vessel wall of the RCA is demonstrated 45 minutes after contrast administration. The RCA vessel lumen or vessel
wall is indicated by white arrows.
This scan was also used for localization of the respiratory
navigator. Next, an axial mid-ventricular cine-segmented k-
space gradient echo imaging sequence with 50 cine frames
was performed to visually determine the individual rest
period of the coronaries in diastole. Timing of the coronary
MRI acquisition within the cardiac cycle (trigger delay)
was then adapted to each patient’s individual coronary
artery rest period. For gating and subsequent correction of
diaphragmatic motion during free breathing, a navigator
(gating window: 5mm) was placed at the dome of the right
hemidiaphragm.
A bolus of 0.1mmol/kg bodyweight Gd-DTPA (low/
single-dose) (Magnevist, Berlex Laboratories, Montville,
New Jersey, USA) at an injection rate of 2mL/s, followed
by a ﬂush of 20mL of saline solution at the same rate,
was then administered intravenously. Magnetic resonance
coronary angiography (MRCA) of the right or left coronary
artery system after contrast was performed with a previously
describednavigator-gatedfree-breathingandfat-suppressed,
cardiac-triggered T2-prepared segmented k-space gradient
echo imaging sequence [15]. The acquired voxel size was
0.70 × 1.01 × 3.00mm3, reconstructed to 0.70 × 0.70 ×
1.50mm3.
The subsequent LGE scans of the coronary vessel wall
were performed with a navigator-gated free breathing and
cardiac-triggered T1-weighted inversion-recovery and fat-
suppressed 3D black-blood segmented k-space gradient
echo imaging sequence. Parameters of the sequence were.
TR/TE/ﬂip angle = 4.7ms/1.6ms/20◦. Spatial resolution of
the sequence was 0.99 × 1.04 × 2.00mm3 and reconstructed
to 0.53 × 0.53 × 1.00mm3. The inversion time (TI) of the
inversion recovery sequence used to null blood was typically
>300ms. Parallel imaging (SENSE (sensitivity encoding),
reduction factor 2) was used, as it allows for shorter scan
times. Scans of the right and left coronary artery system
were performed in the same orientation as the earlier
acquired T2prep-images, to ensure adequate coregistration.
The duration of a typical LGE scan was between 2:14 and
4:46 minutes depending on the heart rate and breathing
pattern of the patient. This scan protocol for LGE of the
coronaries was repeated as often as possible from 30 minutes
to a maximum of 75 minutes after contrast administration.4 Cardiology Research and Practice
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Figure 3: (a) MR-coronary angiography of the RCA (white arrows) showing intraluminal signal loss at medial and distal RCA as
demonstrated by coronary angiography (d) (black arrows). Reformatted inversion recovery MR images: (b) 33 minutes; (c) age range 50
minutes; (e) 68 minutes, and (f) 77 minutes post contrast administration demonstrate strong enhancement of the coronary vessel wall at
the earliest time-points and signal loss over the time-intervals (white arrows). Note strong enhancement of the vessel wall of the aortic arch
(dashed arrows) in contrast to the loss of enhancement of the RCA (solid arrows) and LCX (interrupted arrows) over time. There is also
enhancement of the pulmonary artery (asterisk).
In the four healthy subjects and two of the CAD patients,
inversion recovery measurements were performed prior to
contrast administration.
2.3. MR Image Analysis. The unprocessed MRI images were
used to assess the coronary artery segments on a segment-
by-segment basis as visible or nonvisible on T2prep-images
by consensus of two interpreters blinded to the XCA
results, clinical data, and time postadministration of Gd.
For assessment of coronary artery segments, a quantitative
coronary analysis tool (Soap-Bubble Tool) [16]w a su s e d .
Coronary artery segments were classiﬁed using a modiﬁed 7-
segment-model,accordingtotherecommendationsfromthe
AHA [17]. In brief, this included the left main and proximal
and mid segments of the left anterior descending artery
(LAD), left circumﬂex artery (LCX), and right coronary
artery (RCA). Coronary artery segments with stents or
coronaryarterybypassgrafts(CABG)artifactswereexcluded
because of potential artifacts.
I ne v e r ya c q u i r e ds c a n ,a l lc o r o n a r ya r t e r ys e g m e n t s
with LGE were assigned to the corresponding coronary
segments seen on T2prep-images and the number of
enhanced segments as well as the degree of enhancement was
recorded. LGE of the coronary vessel wall was rated on a
3-point-scale: 0 = no enhancement, 1 = mild to moderate
enhancement, and 2 = strong enhancement. In addition,
the presence or absence of aortic wall enhancement of
the ascending and descending aorta was assessed and the
degree of enhancement using the same 3-point scale was
documented.
The data were then grouped into three time-intervals
based on how long after contrast administration the images
were obtained. Time-interval 1 was 30–45 minutes after
contrast, time-interval 2 was 46–60 minutes after contrast,
and time-interval 3 was 61–75 minutes postcontrast.
Contrast between coronary vessel wall LGE and blood
was quantiﬁed. Regions of interest were drawn at the
coronary vessel wall and in the blood pool and signal
intensities (SI) were recorded. Contrast was determined by
dividing the SI of coronary wall LGE by SI of blood.
2.4. Statistical Analysis. Statistical analysis was performed
using SPSS for Windows (release 12.0.1; SPSS, Chicago, Ill,
USA).Allcontinuous parameters wereshown asmean ± oneCardiology Research and Practice 5
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Figure 4: Prevalence (%) of LGE in coronary artery segments with
and without wall irregularities at coronary X-ray angiography in
CAD patients over time.
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Figure 5: Bar graph demonstrating the average-LGE score over
time in coronary artery segments and aorta.
∗indicates statistical
signiﬁcance (p<0.05).
standard deviation (SD). The Chi-square-test was used to
compare the prevalences of LGE of the coronary vessel wall
among the three time-intervals. Logistic regression analysis
was used to test for trend for the prevalence of LGE among
the three time-intervals. For comparison of inter-observer
variability related to coronary vessel wall enhancement on a
per-segment basis, kappa values were calculated. To detect
diﬀerences in the mean coronary and aortic LGE scores
among the three time-intervals, the Kruskal-Wallis test was
performed. Wilcoxon signed-rank test was used to compare
the visual assigned score of the degree of LGE among
the diﬀerent time-intervals for the coronary as well as the
aortic vessel wall and to compare aortic wall LGE and
coronary vessel wall LGE at every time-interval. To account
for multiple comparisons of LGE among the three time-
intervals, the p-value was corrected using the Bonferroni
method. A p-value of <0.05 was considered statistically
signiﬁcant.
3. Results
Three patients were excluded from the analysis because
of nondiagnostic contrast-enhanced images: one for ECG
triggering diﬃculties, one for inadequate nulling of blood
signal, and another who terminated the study prematurely
because of discomfort while in the MRI scanner. MR
coronary artery imaging was successfully performed in
the four healthy subjects and the remaining eight CAD
patients. Thirty-one inversion recovery measurements were
performed (one in every healthy subject and 3.4 ± 2.3
per CAD patient). LGE was seen in none of the healthy
subjects. All 27 measurements demonstrated LGE in at
least one of the evaluated coronary artery segments. In
the two patients in whom inversion recovery scans were
performed prior to contrast administration, twelve segments
were evaluable and no segment demonstrated LGE prior
to contrast administration. However, all of these segments
showed enhancement post contrast (Figure 1).
3.1. MR Angiographic Parameters. There was substantial
agreement between both observers in the determination of
coronary artery vessel wall enhancement on a per-segment
basis (κ = 0.74; p<0.001). At time-interval 1, data
of 7 patients; at time-interval 2, data of 6 patients, and
at time-interval 3, data of 5 patients were available for
analysis. The prevalence of LGE of the coronary vessel wall
was not signiﬁcantly diﬀerent when comparing the three
time-intervals. Fifty-six of 62 (90.3%) visible segments by
T2Prep showed coronary vessel wall LGE at time-interval
1. At time-interval 2, 34 of 42 (81.0%) segments showed
enhancement and at time-interval 3, 29 of 39 segments
(74.4%) were enhanced (Figure 3). A comparison of the
prevalence of LGE between time-interval 1 and 2 as well
as between time-interval 2 and 3 revealed no statistically
signiﬁcant diﬀerence (p = 0.17 and p = 0.48). How-
ever, logistic regression analysis demonstrated a signiﬁcant
trend to a lower prevalence of LGE from the earliest,
time-interval 1, to the latest time-interval, time-interval 3,
(p = 0.03).
In a subgroup of 3 patients who had undergone coronary
X-ray angiography within 3 months of MRI, the prevalence
(%) of LGE in coronary artery segments with and without
wall irregularities at coronary X-ray angiography in CAD
patients over time is shown in Figure 4. The highest preva-
lence of LGE in coronary segments with CAD was found at
time-interval 1.
The mean coronary vessel wall LGE score was similar for
the ﬁrst two intervals (time-interval 1: 1.29 ± 0.64 and time-
interval 2: 1.28 ± 0.80), although the enhancement at time-
interval 3 (0.97 ± 0.71) was signiﬁcantly lower than that at
time-interval 1 (p = 0.027).
The average aortic wall enhancement was similar for
the three time-intervals (time-interval 1: 1.50 ± 0.80; time-
interval 2: 1.81 ± 0.40; time-interval 3: 1.81 ± 0.54) and did6 Cardiology Research and Practice
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Figure 6: (a) Formatted coronary magnetic resonance angiography (MRCA) of the LAD and LCX demonstrating no high-grade stenosis,
but a stent artifact in the mid LAD which is indicated by a red arrow. (b) No enhancement of the coronary artery vessel wall can be observed
on the pre-contrast inversion-recovery coronary vessel wall scans. (c) Contrast uptake of coronary artery vessel wall of the LAD and LCX
is demonstrated 30 minutes after contrast administration. The vessel wall of the left main (d); LAD (e), and LCX (f) is indicated by white
arrows.
not diﬀer signiﬁcantly (p = 0.293) as a function of time
post-contrast. A signiﬁcantly higher degree of enhancement
of the aortic wall after 46–60 minutes (p = 0.005) and after
61–75 minutes (p = 0.02) was found when compared to
coronary vessel wall enhancement at the same time-interval
(Figure 5).
The mean coronary vessel wall to blood signal contrast
was similar at all three time-intervals. The contrast ratio at
time-interval 1 (1.62 ± 0.49) was not signiﬁcantly diﬀerent
from that at time-interval 2 (1.57 ± 0.42) (p = 0.63), and
that at time-interval 2 was not signiﬁcantly diﬀerent from
that of time-interval 3 (1.58 ± 0.35) (p = 0.69). Similarly,
no diﬀerence between time-interval 1 and time-interval 3
(p = 0.88) was found.
4. Discussion
This study of healthy subjects and patients with stable
CAD demonstrates several important ﬁndings: LGE of the
coronary artery vessel wall was commonly detected at 3.0T
after single administration of low-dose Gd in patients with
X-ray-deﬁned CAD but not in healthy subjects. Secondly, in
CAD patients, a substantial enhancement in the majority of
the evaluated segments was already present between 30 and
45 minutes after contrast administration.
One theoretical advantage of 3.0T over 1.5T includes an
increase of the signal-to-noise ratio and therefore the ability
to achieve a higher spatial resolution and/or accelerated
image acquisition. These potential advantages make 3.0T
well suited for coronary artery imaging [18–20].
To our knowledge, there are only a few published
studies [1, 11, 13] or case reports [12] describing LGE of
the coronary artery vessel wall at 1.5T. For cardiovascular
magnetic resonance (CMR) [21]a n de s p e c i a l l yL G Eo f
myocardial scar tissue, one of the major advantages of
3.0T versus 1.5T seems to be the possibility of a reduced
contrast agent dose [22] as well as the potential for higher
spatial and temporal resolution [23]. Previous reports on
LGE of the coronary vessel wall at 1.5T reported the use
of contrast dosages from 0.2mmol/kg/body weight [11–
13] to 0.3mmol/kg/body weight [1], which is two to
three times higher than the dosage used in our studyCardiology Research and Practice 7
(0.1mmol/kg/body weight of Gd-containing contrast) in
patients with a normal glomerular ﬁltration rate (81.3 ±
22.6mL
∗min−1∗(1.73m2)−1). The ability to use a lower
contrast agent dose is promising, especially in light of
recentlypublishedreportsidentifyingapossiblelinkbetween
a scleroderma-like disorder, nephrogenic systemic ﬁbrosis
(NSF), and exposure to Gd-containing contrast agents in
patientswithend-stagerenaldisease[24].Independentofthe
potential risks of NSF, single dose of Gd reduces the costs per
exam.
We obtained measures of coronary LGE at 3.0T. We used
a slightly higher spatial resolution for LGE of the coronary
artery vessel wall (0.99×1.04×2.00mm3)a t3 . 0Tc o m p a r e d
to previously published 1.5T studies from Maintz et al.
(1.00 × 1.00 × 3.00mm3)[ 1]a n dY e o ne ta l .( 1 .25 × 1.25 ×
3.00mm3)[ 13].
In previously published studies at 1.5T, the time of
LGE measurements of the coronary vessel wall varied widely
and ranged from 30 minutes after contrast [11, 12]t o6 0
minutes [13] and even 3 hours after Gd administration [1].
No characterization of the time course of the enhancement
process has been reported. In our study group, a signiﬁcant
trend for a higher prevalence of LGE (p = 0.03) at the
earliest time-interval was demonstrated, with substantial
enhancement of the coronary artery vessel wall already
present at 30–45 minutes after contrast administration
(Figure 6). In addition, quantitative measurements of mean
coronary vessel wall contrast enhancement were similar at all
three observed time-intervals. In our study, the prevalence
of LGE was relatively high when compared to earlier reports
from studies conducted at 1.5T. This may be attributable to
diﬀerences between the patient cohorts and/or in the time
interval between Gd injection and imaging. These are some
of the earliest coronary wall LGE data following contrast
administration and the limited available data suggest that
the percent of enhanced-CAD segments is higher shortly
after contrast administration than at later times (Figure 4).
The optimal timing of MRI after contrast administration
to precisely characterize coronary atherosclerosis may well
requireadditionalstudiesdirectlycomparingthetimecourse
of LGE to the histopathologic extent of local coronary
atherosclerosis.
Yeonetal.comparedLGE-measurementsofthecoronary
vessel wall with coronary plaque detection by multislice-
computed tomography (MSCT) and >20% luminal narrow-
ing by XCA in patients with coronary risk factors [13]. They
reported that among their patients generally demonstrated
coronary artery wall enhancement and 66% of the evaluable
segments showed LGE. In our study, all of whom had
established and severe CAD, 82.2% of all coronary segments
demonstrated LGE. In the same study by Yeon et al., the
prevalence of LGE increased with severity of coronary artery
disease by MSCT along the spectrum from no plaque to
noncalciﬁed plaque to calciﬁed plaque. The authors stated
thatLGEcontrastuptakemaybeassociatedwithanincreased
distributionvolume(aswithﬁbrosisandneovascularization)
in the altered vessel wall or with increased vascular perme-
ability (as may occur with inﬂammation). In our study, no
evidence of LGE before contrast was found but related data
were only obtained in all of the healthy and only two of the
patients.
A high degree of aortic wall enhancement was observed
for all 3 time-intervals and the visually assessed LGE-score
after 46–60 and 61–75 minutes was greater than that of the
coronary vessel wall at the same time. The greater aortic
vessel wall thickness than that of the coronary arteries may
contribute to this observation. Also the pulmonary artery
trunk showed LGE in healthy subjects and CAD patients,
as seen in Figure 2. A potential reason for this might be
diﬀerentwallcompositionbetweenthecoronaryarteriesand
the pulmonary trunk and should be evaluated in further
studies.
In a clinical setting, our ﬁndings may have important
implications for the design of MRI protocols that include
post-contrast imaging of the coronary artery vessel wall. On
one hand, coronary artery vessel wall enhancement can be
studied early after the administration of the contrast agent
which abbreviates overall scanning time. On the other hand,
c o r o n a r yL G Ec a nb ea d d e dt ot h ee n do fam o r ep r o l o n g e d
comprehensive cardiac MRI exam up until 60 minutes after
contrast injection, albeit at the expense of a slightly reduced
conspicuity of the contrast between enhanced and non-
enhanced-coronary vessel wall.
5. Limitations
The number of subjects in this study is relatively small, but
consistent with other initial studies of a new technology
implemented at higher magnetic ﬁeld strength. No direct
comparison was made to subjects examined at 1.5T or
to diﬀerent doses of Gd. Furthermore, scans were not
performed at every time-interval in every patient, due to the
inability of many CAD patients to tolerate long scan times.
However, the ﬁndings here better deﬁne the time course of
LGE after Gd contrast administration and may help to guide
protocol deﬁnition of future studies related to LGE of the
coronary arteries.
No comparison with histopathologic data was per-
formed, as coronary pathologic data are only available at
autopsy. In addition, we did not compare LGE of the coro-
nary vessel wall with intravascular ultrasound, the current in
vivo gold standard for coronary plaque assessment.
Unfortunately only 3 patients had recent X-ray coronary
angiograms to verify the presence of atherosclerosis in the
enhanced segments. It would be important in future studies
to include more patients and directly compare invasive X-ray
or IVUS with pre- and post-contrast LGE of the coronary
vessel wall to better characterize the type and extent of
atherosclerosis in LGE regions (as opposed to non-LGE
regions). The eﬀect of diﬀerent time intervals on LGE of
the coronary vessel wall compared to patients with cardiac
risk factors but no established clinical disease needs to
be addressed in future studies. In addition, non-contrast
imaging of the coronary vessel wall prior to the acquisition
of contrast-enhanced coronary vessel wall imaging should be
considered.
The LGE sequence was initially developed for visual-
ization of myocardial scar and is routinely used in clinical8 Cardiology Research and Practice
practice between 10 and 20 minutes post-contrast adminis-
tration [25]. However, image quality at this relatively early
time point may be limited by contrast agent which has
not completely washed out of the blood-pool. For this
reason, LGE coronary imaging was performed 30 minutes
and beyond in the present study. To optimize image quality
in every scan, a look-locker-sequence [26]f o ra na c c u r a t e
deﬁnition of the inversion time for blood-signal nulling
may be useful as well. However, 30 minutes after the
administration of a single dose of Gd, the T1 changes are
expected to be minimal.
Finally, due to the use of SENSE, a quantitative signal-to-
noise (SNR) and contrast-to-noise (CNR) evaluation of the
coronary artery vessel wall was not performed.
6. Conclusions
In healthy subjects, no coronary LGE was seen. In patients
with stable CAD, the combination of 3T MRI and a single,
low dose Gd injection enabled the detection of coronary LGE
overarelativelylongperiodoftime.Mostcoronarysegments
showed LGE with the largest proportion of the evaluated
coronary segments already enhancing 30–45 minutes after
Gd-administration. This new information will likely have
important implications for the design of MRI protocols that
include post-contrast imaging of the coronary artery vessel
wall.
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